Levodopa

The potential of nilotinib in the treatment of movement disorders 6:36
The potential of nilotinib in the treatment of movement disorders
Charbel Moussa • 28 Nov 2022
Subcutaneous levodopa/carbidopa infusion for Parkinson’s disease 0:50
Subcutaneous levodopa/carbidopa infusion for Parkinson’s disease
Eric Freire-Alvarez • 15 Sep 2022
Continuous dopaminergic stimulation: Advanced treatments in Parkinson’s disease 1:14
Continuous dopaminergic stimulation: Advanced treatments in Parkinson’s disease
Per Odin • 17 Sep 2022
New MDS task force on early-onset Parkinson’s disease 5:15
New MDS task force on early-onset Parkinson’s disease
Rodolfo Savica • 16 Sep 2022
COMT inhibitors for Parkinson’s disease: clinical updates 1:06
COMT inhibitors for Parkinson’s disease: clinical updates
Margherita Fabbri • 17 Sep 2022
Unmet needs across movement disorders 1:33
Unmet needs across movement disorders
Fabrizio Stocchi • 16 Sep 2022
How can continuous dopaminergic delivery improve outcomes in PD? 0:51
How can continuous dopaminergic delivery improve outcomes in PD?
Eric Freire-Alvarez • 16 Sep 2022
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine 0:52
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine
Torsten Falk • 17 Sep 2022
Extending the efficacy of levodopa in patients with Parkinson’s disease 1:13
Extending the efficacy of levodopa in patients with Parkinson’s disease
Torsten Falk • 17 Sep 2022
Low-dose ketamine produces long-term reduction in levodopa-induced dyskinesia 3:22
Low-dose ketamine produces long-term reduction in levodopa-induced dyskinesia
Torsten Falk
Identifying and characterizing non-motor fluctuations in PD 2:54
Identifying and characterizing non-motor fluctuations in PD
K. Ray-Chaudhuri • 17 Sep 2022
Current treatment options for neurodegenerative movement disorders 1:28
Current treatment options for neurodegenerative movement disorders
Rodolfo Savica • 16 Sep 2022
Investigations into managing non-motor fluctuations 2:33
Investigations into managing non-motor fluctuations
K. Ray-Chaudhuri • 17 Sep 2022
Focusing on quality of life in Parkinson’s disease 1:04
Focusing on quality of life in Parkinson’s disease
Carlo Alberto Artusi • 16 Sep 2022
Early identification of suboptimal PD control to improve care 0:59
Early identification of suboptimal PD control to improve care
Eric Freire-Alvarez • 15 Sep 2022
The treatment of OFF episodes in Parkinson’s disease 1:33
The treatment of OFF episodes in Parkinson’s disease
Fabrizio Stocchi • 16 Sep 2022
The content of VJNeurology is intended for healthcare professionals